Table 3 Distribution of symptoms between Delta variant, Omicron variant and non-detectable variant (ND)
Symptoms | Delta (n = 11) | Omicron (n = 40) | ND (n = 62) | Total (n = 113) |
|---|---|---|---|---|
General symptoms | ||||
Hystory of fever | 10 (90.9%) | 36 (90%) | 48 (77.4%) | 94 (83.2%) |
Respiratory symptoms | ||||
Cough | 6 (54.5%) | 18 (45%) | 22 (35.4%) | 46 (40.7%) |
Runnynose (Rhinorrhoea) | 5 (45.4%) | 8 (2%) | 18 (29.0%) | 31 (27.4%) |
Earpain | 1 (9.0%) | 0 (0%) | 0 (0%) | 1 (0.9%) |
Wheezing | 2 (18.1%) | 1 (0.2%) | 4 (6.4%) | 7 (6.2%) |
Shortness of breath (Dyspnea) | 2 (18.1%) | 3 (0.7%) | 9 (14.5%) | 14 (12.4%) |
Muscoloskeletal symptoms | ||||
Muscle aches (Myalgia) | 0 (0%) | 0 (0%) | 6 (9.8%) | 6 (5.3%) |
Joint pain (Arthralgia) | 1 (9.0%) | 0 (0%) | 3 (4.8%) | 4 (3.5%) |
Fatigue / Malaise | 1 (9.0%) | 1 (0.2%) | 10 (16.1%) | 12 (10.6%) |
Neurological symptoms | ||||
Headache | 1 (9.0%) | 3 (0.7%) | 4 (6.5%) | 8 (7.0%) |
Altered consciousness/confusion | 0 (0%) | 1 (2.5%) | 6 (9.8%) | 7 (6.2%) |
Seizures | 0 (0%) | 4 (10%) | 5 (8.0%) | 9 (8.0%) |
Gastrointestinal symptoms | ||||
Abdominal pain | 1 (9.0%) | 1 (2.5%) | 8 (12.9%) | 10 (8.8%) |
Vomiting / Nausea | 5 (45.4%) | 10 (25%) | 18 (29.0%) | 33 (29.2%) |
Diarrhoea | 2 (18.1%) | 4 (15%) | 9 (14.5%) | 15 (13.2%) |
Hypoalimentation | 6 (54.5%) | 15 (37.5%) | 33 (53.2%) | 54 (47.8%) |
Skinmucosal symptoms | ||||
Conjunctivitis | 0 (0%) | 1 (2.5%) | 2 (3.2%) | 3 (2.7%) |
Skin rash | 1 (9.0%) | 2 (5%) | 5 (8.0%) | 8 (7.0%) |
Lymphadenopathy | 0 (0%) | 2 (5.4%) | 3 (4.8%) | 5 (4.4%) |